Stock events for Integer Holdings Corp. (ITGR)
Over the past six months, Integer Holdings Corp. stock has experienced several events and price movements. The stock's 52-week low was $62.00 on October 30, 2025, and its 52-week high was $127.56 on April 29, 2025. As of April 10, 2026, the stock price was $85.11. Integer reported its Q3 2025 earnings on October 23, 2025, with the Cardio & Vascular segment showing double-digit growth. On February 19, 2026, Integer reported its Q4 and full year 2025 results, announcing a 5% year-over-year revenue growth in Q4 2025 and an 8% sales increase for the full year 2025. Integer participated in investor conferences in February 2026, reaffirming long-term goals for organic sales and operating income growth. James Flanagan and Aaron Kapito were appointed to the Board of Directors on March 12, 2026, and a Board Leadership Transition was announced on April 6, 2026. Integer announced a conference call to discuss its first-quarter 2026 results on April 2, 2026.
Demand Seasonality affecting Integer Holdings Corp.’s stock price
The provided information does not explicitly detail demand seasonality for Integer Holdings Corp.'s products and services. Demand is influenced by product innovation and market approvals rather than explicit seasonal patterns. Analysts expect revenue to remain flat over the next 12 months, implying some demand headwinds, but this is not attributed to seasonality.
Overview of Integer Holdings Corp.’s business
Integer Holdings Corporation is a leading medical device contract development and manufacturing organization that partners with medical device companies and original equipment manufacturers globally. The company operates within the healthcare sector, specifically in the medical devices industry, and is classified under surgical and medical instrument manufacturing. Integer's business is primarily focused on serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets. The company's main product lines include Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation, and Other Markets. Key brands include Greatbatch Medical and Lake Region Medical.
ITGR’s Geographic footprint
Integer Holdings Corp. has a global geographic footprint, with its corporate headquarters located in Plano, Texas, USA. The company earns a significant portion of its revenue in the United States. Beyond the U.S., Integer has a presence in Ireland, Puerto Rico, Costa Rica, the Dominican Republic, Malaysia, Mexico, Switzerland, and Uruguay, encompassing administrative, manufacturing, and R&D locations.
ITGR Corporate Image Assessment
Based on the provided search results, there is no explicit section or direct mention of brand reputation or specific events that have negatively or positively impacted Integer Holdings Corp.'s brand reputation in the past year. The news and SEC filings primarily focus on financial performance, management changes, product developments, and investor relations.
Ownership
Integer Holdings Corporation's stock is predominantly held by institutional investors, reflecting strong market confidence. Approximately 66.19% to 99.29% of the company's stock is owned by institutional investors. Major institutional shareholders include BlackRock, Inc., Vanguard Group Inc., Dimensional Fund Advisors Lp, State Street Corp, Invesco Ltd., Irenic Capital Management LP, Alliancebernstein L.p., Earnest Partners Llc, Geode Capital Management, Llc, and Morgan Stanley. Vanguard Group Inc. is noted as the largest institutional shareholder. Individual investors and insiders hold a smaller percentage, with insiders holding around 1.01% to 2.16% of the stock.
Ask Our Expert AI Analyst
Price Chart
$87.51